Zoetis (ZTS) falls on buyout rumors

Zoetis (NYSE: ZTS) shares scaled back 9.7% to $49.99, as the animal-health company has been approached by Valeant Pharmaceuticals International Inc. for a potential buyout. Share volume was 1.5 million, twice its all-day average